England’s NHS will begin offering seven-minute cholesterol checks at around 100 high-street pharmacies this autumn, in a move aimed at catching cardiovascular risk earlier and reducing heart disease and stroke deaths over the next decade.
The programme is open to people aged 40 to 84 who are not pregnant and have not had a blood test in the past year. Eligible patients will be able to walk into participating pharmacies for a quick pin-prick test, with results analysed in just seven minutes. A pharmacist prescriber can then provide lifestyle advice, decide whether treatment is needed and, where appropriate, offer a blood pressure check during the same clinical consultation.
A pharmacy-based approach to prevention
The rollout follows a smaller pilot in north London run by Barts Health NHS Trust in collaboration with UCLPartners and HEART UK. That pilot tested 2,493 patients at 61 community pharmacies between January 2025 and March 2026, with 19 per cent found to be suitable for pharmacological intervention and 88 people started on statins.
David Webb, chief pharmaceutical officer for England, said local pharmacies can act as a first line of defence against serious illness, while Health Minister Alison McGovern described the programme as the kind of innovation the NHS wants to see across the service. NHS England’s National Specialty Advisor for Cardiovascular Disease Prevention, Dr Rani Khatib, said the initiative is intended to help people “know their numbers” and reduce the risk of heart attacks and strokes by identifying high cholesterol and blood pressure earlier.
Why the NHS is pushing prevention now
The new checks are part of the NHS drive to reduce heart disease and stroke deaths by a quarter over the next decade. Officials say the pharmacy model is designed to bring care closer to where people live, while easing pressure on GP surgeries and helping patients access advice more conveniently.
Barts Health clinical lead Dr Sotiris Antoniou said scaling the model across England could support earlier cardiovascular risk detection and more timely treatment, with the potential to improve outcomes and reduce health inequalities in communities where cardiovascular disease is most common. UCLPartners chief executive Chris Laing said the evidence from north London showed that one in five people tested were at high risk of a heart attack or stroke over the following 10 years.
The NHS pilot will run until spring 2027, giving health leaders a further opportunity to assess whether community pharmacy can become a wider route into prevention for patients who may otherwise miss routine checks. For now, the focus is on identifying risk sooner and acting before avoidable disease develops. NHS England announcement
Photo source: AI-generated or edited image
